| Literature DB >> 14281087 |
L LEVI, W N FRENCH, I J BICKIS, I W HENDERSON.
Abstract
A study was made of the composition and biochemical behaviour of the drug, Laetrile, distributed for clinical trial in the United States and Canada. It was established that the Canadian and the American product are different pharmaceutical formulations, displaying different physicochemical and biochemical properties. The investigation demonstrated, furthermore, that neither preparation can be considered as a palliative in cancer therapy on the basis of the biological rationale advanced by their manufacturers.Entities:
Keywords: ANTINEOPLASTIC AGENTS; BIOCHEMISTRY; CYANIDES; DRUG THERAPY; NEOPLASM THERAPY; PALLIATIVE TREATMENT; PHARMACOLOGY
Mesh：
Substances：
Year: 1965 PMID： 14281087 PMCID： PMC1928277
Source DB: PubMed Journal: Can Med Assoc J ISSN： 0008-4409 Impact factor: 8.262